FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2352375444> ?p ?o ?g. }

• W2352375444 endingPage "336" @default.
• W2352375444 startingPage "334" @default.
• W2352375444 abstract "OBJECTIVE To study the specific cellular immunoresponse of peripheral blood lymphocytes in the chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine. METHODS Seventy-two chronic hepatitis B patients who did not use any anti-HBV drugs within 6 months were randomized into 3 groups (90 micrograms, 60 micrograms, and placebo) in a ratio of 1:1:1. The patients in different groups were treated with different doses of recombinant hepatitis B vaccine in combination with IFN alpha 1b 50 micrograms with 3 times a week for 24 weeks. All patients were followed up for 24 weeks (W24). HBV DNA, HBeAg and liver functions were detected at different time points, and the number of cells that secrete IFN-gamma were detected by ELISPOT. RESULTS There were no significant difference in ELISPOT positive ratio among the 3 groups on baseline detection. At W24, 12 cases, 12 cases, and 7 cases showed ELISPOT positive in the group of 90 micrograms, 60 micrograms, and placebo. The proportion of patients who were ELISPOT positive was higher in the groups treated with recombinant hepatitis B vaccine (including the dose of 90 micrograms and 60 micrograms) than that in the placebo group (P=0.0446). HBV DNA turned negative in 6/24 of the patients treated with recombinant hepatitis B vaccine (at both the doses of 90 micrograms and 60 micrograms), and HBeAg/Anti-HBe seroconversion or HBeAg became negative in 7/24 of them. In the placebo group, none of the patients showed undetectable HBV DNA, HBeAg/Anti-HBe seroconversion or HBeAg disappearance. At the 24W of follow up, in the patients who were ELISPOT positive, HBV DNA became undetectable in 4 of the patients treated with recombinant hepatitis B vaccine (at doses of 90 micrograms and 60 micrograms), and HBeAg/Anti-HBe seroconversion or HBeAg disappearance were found in 9 of the cases. In the placebo group, none of the cases showed undetectable HBV DNA, and only 1 case had HBeAg/Anti-HBe seroconversion. CONCLUSION The recombinant hepatitis B vaccine may increase the function of specific T lymphocytes in patients with chronic hepatitis B. There were no significant differences between the patients treated with the dose of 90 micrograms and 60 micrograms hepatitis B vaccine." @default.
• W2352375444 created "2016-06-24" @default.
• W2352375444 creator A5008182583 @default.
• W2352375444 creator A5017068466 @default.
• W2352375444 creator A5027383771 @default.
• W2352375444 creator A5031587845 @default.
• W2352375444 creator A5032658910 @default.
• W2352375444 creator A5046415582 @default.
• W2352375444 creator A5053377932 @default.
• W2352375444 creator A5068255173 @default.
• W2352375444 date "2007-12-01" @default.
• W2352375444 modified "2023-09-27" @default.
• W2352375444 title "Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine" @default.
• W2352375444 doi "https://doi.org/10.3760/cma.j.issn.1003-9279.2007.04.012" @default.
• W2352375444 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18322594" @default.
• W2352375444 hasPublicationYear "2007" @default.
• W2352375444 type Work @default.
• W2352375444 sameAs 2352375444 @default.
• W2352375444 citedByCount "0" @default.
• W2352375444 crossrefType "journal-article" @default.
• W2352375444 hasAuthorship W2352375444A5008182583 @default.
• W2352375444 hasAuthorship W2352375444A5017068466 @default.
• W2352375444 hasAuthorship W2352375444A5027383771 @default.
• W2352375444 hasAuthorship W2352375444A5031587845 @default.
• W2352375444 hasAuthorship W2352375444A5032658910 @default.
• W2352375444 hasAuthorship W2352375444A5046415582 @default.
• W2352375444 hasAuthorship W2352375444A5053377932 @default.
• W2352375444 hasAuthorship W2352375444A5068255173 @default.
• W2352375444 hasConcept C104317684 @default.
• W2352375444 hasConcept C126322002 @default.
• W2352375444 hasConcept C142724271 @default.
• W2352375444 hasConcept C159047783 @default.
• W2352375444 hasConcept C159654299 @default.
• W2352375444 hasConcept C203014093 @default.
• W2352375444 hasConcept C204787440 @default.
• W2352375444 hasConcept C2522874641 @default.
• W2352375444 hasConcept C27081682 @default.
• W2352375444 hasConcept C2775940106 @default.
• W2352375444 hasConcept C2776090121 @default.
• W2352375444 hasConcept C2777382497 @default.
• W2352375444 hasConcept C2777410769 @default.
• W2352375444 hasConcept C2777451964 @default.
• W2352375444 hasConcept C2778600374 @default.
• W2352375444 hasConcept C2779053233 @default.
• W2352375444 hasConcept C2780593183 @default.
• W2352375444 hasConcept C2780617729 @default.
• W2352375444 hasConcept C2781037505 @default.
• W2352375444 hasConcept C40767141 @default.
• W2352375444 hasConcept C55493867 @default.
• W2352375444 hasConcept C71924100 @default.
• W2352375444 hasConcept C86803240 @default.
• W2352375444 hasConcept C8891405 @default.
• W2352375444 hasConcept C90924648 @default.
• W2352375444 hasConceptScore W2352375444C104317684 @default.
• W2352375444 hasConceptScore W2352375444C126322002 @default.
• W2352375444 hasConceptScore W2352375444C142724271 @default.
• W2352375444 hasConceptScore W2352375444C159047783 @default.
• W2352375444 hasConceptScore W2352375444C159654299 @default.
• W2352375444 hasConceptScore W2352375444C203014093 @default.
• W2352375444 hasConceptScore W2352375444C204787440 @default.
• W2352375444 hasConceptScore W2352375444C2522874641 @default.
• W2352375444 hasConceptScore W2352375444C27081682 @default.
• W2352375444 hasConceptScore W2352375444C2775940106 @default.
• W2352375444 hasConceptScore W2352375444C2776090121 @default.
• W2352375444 hasConceptScore W2352375444C2777382497 @default.
• W2352375444 hasConceptScore W2352375444C2777410769 @default.
• W2352375444 hasConceptScore W2352375444C2777451964 @default.
• W2352375444 hasConceptScore W2352375444C2778600374 @default.
• W2352375444 hasConceptScore W2352375444C2779053233 @default.
• W2352375444 hasConceptScore W2352375444C2780593183 @default.
• W2352375444 hasConceptScore W2352375444C2780617729 @default.
• W2352375444 hasConceptScore W2352375444C2781037505 @default.
• W2352375444 hasConceptScore W2352375444C40767141 @default.
• W2352375444 hasConceptScore W2352375444C55493867 @default.
• W2352375444 hasConceptScore W2352375444C71924100 @default.
• W2352375444 hasConceptScore W2352375444C86803240 @default.
• W2352375444 hasConceptScore W2352375444C8891405 @default.
• W2352375444 hasConceptScore W2352375444C90924648 @default.
• W2352375444 hasIssue "4" @default.
• W2352375444 hasLocation W23523754441 @default.
• W2352375444 hasLocation W23523754442 @default.
• W2352375444 hasOpenAccess W2352375444 @default.
• W2352375444 hasPrimaryLocation W23523754441 @default.
• W2352375444 hasRelatedWork W2014085175 @default.
• W2352375444 hasRelatedWork W2031008133 @default.
• W2352375444 hasRelatedWork W2081067572 @default.
• W2352375444 hasRelatedWork W2322220773 @default.
• W2352375444 hasRelatedWork W2354647466 @default.
• W2352375444 hasRelatedWork W2355416117 @default.
• W2352375444 hasRelatedWork W2360307779 @default.
• W2352375444 hasRelatedWork W2366176692 @default.
• W2352375444 hasRelatedWork W2388919234 @default.
• W2352375444 hasRelatedWork W2401558494 @default.
• W2352375444 hasRelatedWork W2415124599 @default.
• W2352375444 hasRelatedWork W2415546697 @default.
• W2352375444 hasRelatedWork W2418936000 @default.
• W2352375444 hasRelatedWork W2425864783 @default.
• W2352375444 hasRelatedWork W2600086138 @default.

• next